Literature DB >> 27043138

A SURVEY OF NONXANTHINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS.

Suhaib M Siddiqi1, Xiao-Duo Ji1, Neli Melman1, Mark E Olah2, Rahul Jain3, Patricia Evans1, Marc Glashofer1, William L Padgett4, Louis A Cohen3, John W Daly4, Gary L Stiles2, Kenneth A Jacobson1.   

Abstract

The binding affinities at rat A1, A2a, and A3 adenosine receptors of a wide range of heterocyclic derivatives have been determined. Mono-, bi-, tricyclic and macrocyclic compounds were screened in binding assays, using either [3H]PIA or [3H]CGS 21680 in rat brain membranes or [125I]AB-MECA in CHO cells stably transfected with rat A3 receptors. Several new classes of adenosine antagonists (e.g. 5-oxoimidazopyrimidines and a pyrazoloquinazoline) were identified. Various sulfonylpiperazines, 11-hydroxytetrahydrocarbazolenine, 4H-pyrido[1,2-a]pyrimidinone, folic acid, and cytochalasin H and J bound to A3 receptors selectively. Moreover, cytochalasin A, which bound to A1 adenosine receptors with Ki value of 1.9 μM, inhibited adenylyl cyclase in rat adipocytes, but not via reversible A1 receptor binding.

Entities:  

Year:  1996        PMID: 27043138      PMCID: PMC4817726          DOI: 10.1080/07328319608002416

Source DB:  PubMed          Journal:  Nucleosides Nucleotides        ISSN: 0732-8311


  32 in total

1.  7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.

Authors:  C E Müller; I Hide; J W Daly; K Rothenhäusler; K Eger
Journal:  J Med Chem       Date:  1990-10       Impact factor: 7.446

2.  Cardiovascular effects of amitriptyline, nortriptyline, protriptyline and doxepin in conscious rabbits.

Authors:  E Elonen; M J Mattila; L Saarnivaara
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

3.  Effect of pertussis toxin treatment on the putative adenosine A3 receptor-mediated hypotensive response in the rat.

Authors:  A M Carruthers; J R Fozard
Journal:  Eur J Pharmacol       Date:  1993-11-30       Impact factor: 4.432

4.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

5.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

6.  Some observations on the pharmacology of mitragynine.

Authors:  E Macko; J A Weisbach; B Douglas
Journal:  Arch Int Pharmacodyn Ther       Date:  1972

7.  Mesoionic xanthine analogues: antagonists of adenosine receptors.

Authors:  R A Glennon; S M Tejani-Butt; W Padgett; J W Daly
Journal:  J Med Chem       Date:  1984-10       Impact factor: 7.446

8.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Behavioural and convulsant actions of two methyl esters of beta-carboline-3-carboxylic acid in photosensitive baboons and in DBA/2 mice.

Authors:  M Croucher; G De Sarro; L Jensen; B Meldrum
Journal:  Eur J Pharmacol       Date:  1984-09-03       Impact factor: 4.432

Review 10.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

View more
  3 in total

1.  The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family.

Authors:  T R Webb; N Melman; D Lvovskiy; X D Ji; K A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2000-01-03       Impact factor: 2.823

Review 2.  Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs.

Authors:  Kenneth A Jacobson; Marc L Reitman
Journal:  Cells       Date:  2020-04-13       Impact factor: 6.600

3.  Pharmacological characterisation of novel adenosine A3 receptor antagonists.

Authors:  Kerry Barkan; Panagiotis Lagarias; Margarita Stampelou; Dimitrios Stamatis; Sam Hoare; Dewi Safitri; Karl-Norbert Klotz; Eleni Vrontaki; Antonios Kolocouris; Graham Ladds
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.